chartexchange

VYGR
Voyager Therapeutics, Inc. Common Stock
stockNASDAQ

At CloseNov 20, 2026 3:59:43 PM EST
1.52USD-5.590%(-0.09)639,269
After-hoursNov 20, 2026 4:00:30 PM EST
1.53USD+0.658%(+0.01)
Loading…
Loading…
Healthcare
Biotechnology
CEO
G. Andre Turenne
HQ
Cambridge, MA, USA
Previous Close
$1.61
Beta
1.48
52-Week High
$5.48 2026-03-11
52-Week Low
$1.48 2026-11-18
SMA 50
$2.21
SMA 200
$3.30
Avg. Vol 10D
903,052
Avg. Vol 30D
998,268
Avg. Vol 90D
704,488
Relative Vol
0.64
52.11M
0.4500%
175
VYGR Profile

voyager therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (cns). voyager is committed to advancing the field of aav (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. the company's initial pipeline is focused on cns diseases in dire need of effective new therapies, including parkinson's disease, a monogenic form of amyotrophic lateral sclerosis (als), and friedreich's ataxia. founded by scientific and clinical leaders in the fields of aav gene therapy, expressed rna interference and neuroscience, voyager therapeutics was launched in 2014 with funding from leading life sciences investor third rock ventures and is headquartered in cambridge, mass. for more information, please visit www.voyagertherapeutics.com.

VYGR Performance
PeriodPriceDateChangeBeta
1W1.732026-11-13-11.85%3.221
1M2.022026-10-21-24.50%1.975
3M3.392026-08-21-55.02%1.758
6M3.682026-05-21-58.56%1.555
1Y4.182025-11-21-63.52%1.475
2Y5.432024-11-21-71.92%—
5Y3.052021-11-22-50.00%1.357
VYGR Stock Summary

Voyager Therapeutics, Inc. Common Stock (NASDAQ:VYGR) stock price today is $1.53, and today's volume is 639,269. VYGR is down 5.280% today. The 30 day average volume is 998,268. VYGR market cap is $94.90M with 62.23M shares outstanding.